Suppr超能文献

前晶状体囊对大分子和小分子药物的通透性。

Permeability of the anterior lens capsule for large molecules and small drugs.

机构信息

Institute for Biomedical Engineering, University of Rostock, Germany.

出版信息

Curr Eye Res. 2013 Oct;38(10):1057-63. doi: 10.3109/02713683.2013.803288. Epub 2013 Jul 25.

Abstract

PURPOSE

For developing injectable lenses the retention properties of the capsular bag are important. Therefore the apparent permeability coefficients of sodium fluorescein and fluorescent dextrans of different sizes were determined for the human anterior lens capsule to calculate a molecular weight cutoff from these data. In addition, permeability coefficients of drugs helpful for the suppression of secondary cataract were determined.

MATERIALS AND METHODS

Capsulorhexis specimens were fixed in a specially designed two compartment diffusion chamber to investigate the permeation of sodium fluorescein and fluorescent dextrans of different sizes (10, 40, 70 and 150 kDa) for 24 h (n ≥ 3) and of the antiproliferative drugs actinomycin D and methotrexate for 0.5, 24, 48 and 72 h (n ≥ 3).

RESULTS

The molecular weight cutoff of the anterior lens capsule was found to be 166 ± 82 kDa. After 0.5 h, no passage of actinomycin D and methotrexate was detectable through the lens capsule. The apparent permeability coefficients for actinomycin D and methotrexate were calculated to 0.71 ± 0.02 µm/s and to 0.80 ± 0.13 µm/s, respectively.

CONCLUSIONS

The capsular bag retains fluorescent dextrans with a molecular weight of >166 kDa. Hence, prepolymers are required to polymerize rapidly to be retained inside of the capsular bag. In addition, low-molecular substances intended as antiproliferative drugs for secondary cataract prevention should be applied within a time frame of five minutes in such a way that cells adjacent to the capsular bag will not be damaged.

摘要

目的

为了开发可注射镜片,囊袋的保持特性很重要。因此,测定了不同大小的荧光素钠和荧光右旋糖的表观渗透系数,以计算从这些数据得出的分子量截止值。此外,还测定了有助于抑制后发性白内障的药物的渗透系数。

材料和方法

将晶状体囊袋的撕囊标本固定在一个特殊设计的两室扩散室中,以研究不同大小(10、40、70 和 150 kDa)的荧光素钠和荧光右旋糖(n ≥ 3)在 24 小时内的渗透情况,以及抗增殖药物放线菌素 D 和氨甲蝶呤在 0.5、24、48 和 72 小时(n ≥ 3)内的渗透情况。

结果

发现前晶状体囊袋的分子量截止值为 166 ± 82 kDa。0.5 小时后,未检测到放线菌素 D 和氨甲蝶呤通过晶状体囊袋。计算得出放线菌素 D 和氨甲蝶呤的表观渗透系数分别为 0.71 ± 0.02 µm/s 和 0.80 ± 0.13 µm/s。

结论

囊袋保留分子量大于 166 kDa 的荧光右旋糖。因此,需要预聚物快速聚合以保留在囊袋内。此外,作为预防后发性白内障的抗增殖药物的低分子量物质,应在五分钟内以不损害囊袋周围细胞的方式使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验